patient derived cd171 specific car t cells expressing egfrt
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2014 (NCT02311621)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Epidermal growth factor receptor erbB1Immunity, passive
EGFR immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- patient derived cd171 specific car t cells expressing egfrt
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02311621 | Phase 1 | Nov 1, 2014 | Ben Towne Center for Childhood Cancer Research, EVAN Foundation, University of Washington |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ben Towne Center for Childhood Cancer Research | Academic/Hospital | 1 | 0 | 1 | 2014 |
| EVAN Foundation | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Washington | Academic/Hospital | 1 | 1 | 1 | 2014 |
3 organizations
Page 1 / 1